avapritinib

CHEBI:CHEBI_746932

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

pharm_class_moa
Bile Salt Export Pump Inhibitors [MoA]
pharm_class
Bile Salt Export Pump Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
generic_name
Avapritinib
rxcui
2559729
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
ORAL
active_ingredient_strength
300 mg/1
dosage_form
TABLET, FILM COATED
nui
N0000193845
marketing_start_date
20200109
pharm_class_epc
Kinase Inhibitor [EPC]
brand_name
Ayvakit
brand_name_base
Ayvakit
product_ndc
63285-869
application_number
NDA212608
labeler_name
Patheon, Inc.
manufacturer_name
Blueprint Medicines Corporation
package_marketing_start_date
23-JUL-19
spl_id
076d2376-4360-c3bb-e063-6394a90a0e3b
active_ingredient_name
AVAPRITINIB
package_ndc
63285-869-03
package_description
120000 TABLET, FILM COATED in 1 DRUM (63285-869-03)
unii
513P80B4YJ
spl_set_id
645c887c-8cd4-4623-8da9-ac223d71a8b9
upc
0372064130307